CoChat

Serum amyloid A: high-density lipoproteins interaction and cardiovascular risk

Open access
Zewinger, Stephen, Drechsler, Christiane, Kleber, Marcus E., Dressel, Alexander, Riffel, Julia, Triem, Sarah, Lehmann, Marlene, Kopecky, Chantal, Säemann, Marcus D., Lepper, Philipp M., Silbernagel, Günther, Scharnagl, Hubert, Ritsch, Andreas, Thorand, Barbara, de las Heras Gala, Tonia, Wagenpfeil, Stefan, Koenig, Wolfgang, Peters, Annette, Laufs, Ulrich, Wanner, Christoph, Fliser, Danilo, Speer, Thimoteus, März, Winfried · 2015 · European Heart Journal
Cited by 150

The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.

Abstract

AIMS: High-density lipoproteins (HDLs) are considered as anti-atherogenic. Recent experimental findings suggest that their biological properties can be modified in certain clinical conditions by accumulation of serum amyloid A (SAA). The effect of SAA on the association between HDL-cholesterol (HDL-C) and cardiovascular outcome remains unknown. METHODS AND RESULTS: We examined the association of SAA and HDL-C with mortality in the Ludwigshafen Risk and Cardiovascular Health (LURIC) study, which included 3310 patients undergoing coronary angiography. To validate our findings, we analysed 1255 participants of the German Diabetes and Dialysis study (4D) and 4027 participants of the Cooperative Health Research in the Region of Augsburg (KORA) S4 study. In LURIC, SAA concentrations predicted all-cause and cardiovascular mortality. In patients with low SAA, higher HDL-C was associated with lower all-cause and cardiovascular mortality. In contrast, in patients with high SAA, higher HDL-C was associated with increased all-cause and cardiovascular mortality, indicating that SAA indeed modifies the beneficial properties of HDL. We complemented these clinical observations by in vitro experiments, in which SAA impaired vascular functions of HDL. We further derived a formula for the simple calculation of the amount of biologically 'effective' HDL-C based on measured HDL-C and SAA from the LURIC study. In 4D and KORA S4 studies, we found that measured HDL-C was not associated with clinical outcomes, whereas calculated 'effective' HDL-C significantly predicted better outcome. CONCLUSION: The acute-phase protein SAA modifies the biological effects of HDL-C in several clinical conditions. The concomitant measurement of SAA is a simple, useful, and clinically applicable surrogate for the vascular functionality of HDL.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/eurheartj/ehv352

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 11 references

Cited by

See all 150

Metadata

Authors
Zewinger, S., Drechsler, C., Kleber, M. E., Dressel, A., Riffel, J., Triem, S., Lehmann, M., Kopecky, C., Säemann, M. D., Lepper, P. M., Silbernagel, G., Scharnagl, H., Ritsch, A., Thorand, B., de las Heras Gala, T., Wagenpfeil, S., Koenig, W., Peters, A., Laufs, U., Wanner, C., Fliser, D., Speer, T., & März, W.
Venue
European Heart Journal
Published
2015-08-06
Volume
36
Issue
43
Pages
ehv352
ISSN
  • 0195-668X (ISSN-L)
  • 1522-9645
OpenAlex
W2238837865
Cited by
150
References
11
FWCI
12.73
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Serum amyloid A: high-density lipoproteins interaction and cardiovascular risk. https://app.cochat.ai/papers/10.1093/eurheartj/ehv352
The paper
Zewinger, S., Drechsler, C., Kleber, M. E., Dressel, A., Riffel, J., Triem, S., Lehmann, M., Kopecky, C., Säemann, M. D., Lepper, P. M., Silbernagel, G., Scharnagl, H., Ritsch, A., Thorand, B., de las Heras Gala, T., Wagenpfeil, S., Koenig, W., Peters, A., Laufs, U., . . . März, W. (2015). Serum amyloid A: high-density lipoproteins interaction and cardiovascular risk. European Heart Journal. https://doi.org/10.1093/eurheartj/ehv352

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.